| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $21.97B | +46.6% |
| Cost of Revenue | $19.54B | +51.2% |
| Gross Profit | $2.43B | +17.9% |
| R&D Expense | $636.5M | +37.3% |
| SG&A Expense | $267.2M | +35.4% |
| Operating Income | $1.25B | +3.5% |
| Pre-tax Income | $1.21B | -0.2% |
| Income Tax | $156.9M | +147.8% |
| Net Income | $1.05B |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.17B | +209.6% |
| Accounts Receivable | $2.20B | -19.5% |
| Inventory | $4.68B | +8.0% |
| Current Assets | $12.30B | +37.7% |
| Total Assets | $14.02B | +42.7% |
| Current Liabilities | $2.34B | -0.0% |
| Total Liabilities | $7.72B | +75.0% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.66B | +166.8% |
| Capital Expenditures | $127.2M | +2.4% |
| Investing Cash Flow | -$183.2M | +5.7% |
| Financing Cash Flow | $2.02B | -48.3% |
| Free Cash Flow | $1.53B | +158.7% |
| -9.0% |
| EPS (Basic) | $1.77 | -14.5% |
| EPS (Diluted) | $1.68 | -12.5% |
| Stockholders' Equity |
| $6.30B |
| +16.3% |